Table 1.
No. | LOCATION | POINT MUTATION | Univ.Lig Affinity (nM ± SEM) |
---|---|---|---|
Wild type hGRPR 0.1×106 | - | 0.100 ± 0.006 | |
1 | UTM2 | L90A | 0.053 ± 0.003 |
2 | T92A | 0.53 ± 0.03* | |
3 | V96A | 0.13 ± 0.42 | |
4 | EC2 | D97N | 1.24 ± 0.01* |
5 | A98L | 0.031 ± 0.007 | |
6 | S99I | 0.010 ± 0.013 | |
7 | R100A | 0.094 ± 0.004 | |
8 | Y101N | 0.038 ± 0.001 | |
9 | Y101A | 0.120 ± 0.01 | |
10 | D104K | 0.20 ± 0.01* | |
11 | R110S | 0.074 ± 0.009 | |
12 | R110A | 0.087 ± 0.003 | |
13 | R110D | 0.026 ± 0.001 | |
14 | G112V | 2.98 ± 0.15* | |
15 | UTM3 | L115A | 0.050 ± 0.031 |
16 | I116A | 0.18 ± 0.01* | |
17 | I119A | 0.11 ± 0.01 | |
18 | L121A | 0.48 ± 0.02* | |
19 | UTM4 | A172T | 0.078 ± 0.009 |
20 | I173T | 0.066 ± 0.008 | |
21 | E175Q | 0.15 ± 0.01* | |
22 | A176G | 0.12 ± 0.01 | |
23 | EC3 | F193A | 0.078 ± 0.011 |
24 | Y199L | 0.069 ± 0.003 | |
25 | P200L | 0.064 ± 0.004 | |
26 | S202N | 0.056 ± 0.003 | |
27 | L205A | 0.096 ± 0.004 | |
28 | M212F | 0.10 ± 0.01 | |
29 | UTM5 | F215A | 0.063 ± 0.005 |
30 | F218A | 0.074 ± 0.001 | |
31 | UTM6 | N280A | 0.037 ± 0.003 |
32 | H281A | 0.22 ± 0.01* | |
33 | I283A | 0.47 ± 0.02* | |
34 | Y284A | 5.78 ± 0.33* | |
35 | EC4 | R287N | 7.07 ± 0.47* |
36 | Y289A | 0.063 ± 0.008 | |
37 | M298P | 0.22 ± 0.01* | |
38 | H300S | 0.99 ± 0.03* | |
39 | S304A | 0.10 ± 0.01 | |
40 | UTM7 | I305A | 0.14 ± 0.01 |
41 | R308A | 0.28 ± 0.02* |
Group I (n=41) comprise point mutants made in a hGRPR amino acids which are present in all BnR’s with high affinity for [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] but which different from that in a similar position in hCCKAR identified as described in Methods. The affinities (IC50) were measured in whole cell radioligand binding assays using 50 pM 125I- [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] as described in Methods and Fig. 3 legend. Each point mutation’s affinity for Univ.Lig was compared to that of cells expressing wild type GRPR which bound comparable amounts of radiolabeled ligand. Data are partially from the dose-inhibition curves of representative mutants shown in Fig. 3. IC50’s, the concentration causing half-maximal inhibition, were calculated from the dose-inhibition curves of [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] as described in Methods. Values are means ± SEM from three experiments for those mutants showing no affinity change and 4 to 6 experiments for any showing differences from control and in each experiment each point was measured in duplicate.
(in bold)=p<0.05 compared to wild type hGRPR expressed at similar expression levels.